
New funds to boost European life sciences
Last November, LSP announced that it had raised €850m for LSP 7 and that it is intending to join forces with EQT, one of the largest European and...

Bayer Leaps to invests €1.3bn externally
"We are on the threshold of a new era of innovation in the life sciences." commented Werner Baumann, Chairman of the Board at Bayer...

Sanofi bags €300m from US investor Blackstone
French Sanofi has secured €300m from US equity financing specialist Blackstone Life Sciences to accelerate pivotal studies of its subcutanous...

EMA delays Valneva vaccine approval
The CHMP’s action puts pressure on the French-Austrian vaccine developer, which wanted to market the vaccine from April on as the UK has already...

Precirix NV raises €80m in Series B financing
The Series B financing round was led by led new investors INKEF Capital, Jeito Capital and Forbion. “The investment will allow Precirix to accelerate...

Vigeneron updates gene therapy collab with Daiichi Sankyo
Under the new agreement, Planegg-based AAV specialist ViGeneron GmbH will provide its novel engineered recombinant adeno-associated virus vectors...